ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Elyashiv, Osnat, Ledermann, Jonathan, Parmar, Gita, Farrelly, Laura, Counsell, Nicholas, Feeney, Amanda, El-Khouly, Fatima, Macdonald, Ian, Neto, Andreia, Arthur-Darkwa, Esther, Burnett, Eva, Jayson, Gordon C, Mileshkin, Linda, Gourley, Charlie, Nicum, Shibani
Published in International journal of gynecological cancer (01.01.2021)
Published in International journal of gynecological cancer (01.01.2021)
Get full text
Journal Article